DXCM Annual Current Liabilities
$1.56 B
-$283.30 M-15.40%
31 December 2023
Summary:
As of January 22, 2025, DXCM annual total current liabilities is $1.56 billion, with the most recent change of -$283.30 million (-15.40%) on December 31, 2023. During the last 3 years, it has risen by +$941.90 million (+153.38%). DXCM annual current liabilities is now -15.40% below its all-time high of $1.84 billion, reached on December 31, 2022.DXCM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Quarterly Current Liabilities
$1.73 B
+$12.30 M+0.71%
30 September 2024
Summary:
As of January 22, 2025, DXCM quarterly total current liabilities is $1.73 billion, with the most recent change of +$12.30 million (+0.71%) on September 30, 2024. Over the past year, it has increased by +$12.30 million (+0.71%). DXCM quarterly current liabilities is now -16.20% below its all-time high of $2.07 billion, reached on June 30, 2023.DXCM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.4% | +0.7% |
3 y3 years | +153.4% | -7.0% |
5 y5 years | +599.6% | -7.0% |
DXCM Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -15.4% | +115.9% | -16.2% | +143.8% |
5 y | 5-year | -15.4% | +332.0% | -16.2% | +406.0% |
alltime | all time | -15.4% | >+9999.0% | -16.2% | >+9999.0% |
DexCom Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.73 B(+0.7%) |
June 2024 | - | $1.72 B(+8.0%) |
Mar 2024 | - | $1.59 B(+2.5%) |
Dec 2023 | $1.56 B(-15.4%) | $1.56 B(-7.3%) |
Sept 2023 | - | $1.68 B(-18.9%) |
June 2023 | - | $2.07 B(+11.0%) |
Mar 2023 | - | $1.86 B(+1.4%) |
Dec 2022 | $1.84 B(+155.2%) | $1.84 B(+104.3%) |
Sept 2022 | - | $900.50 M(+11.6%) |
June 2022 | - | $807.00 M(+13.4%) |
Mar 2022 | - | $711.40 M(-1.3%) |
Dec 2021 | $720.80 M(+17.4%) | $720.80 M(-1.9%) |
Sept 2021 | - | $734.90 M(+22.3%) |
June 2021 | - | $600.70 M(-0.6%) |
Mar 2021 | - | $604.10 M(-1.6%) |
Dec 2020 | $614.10 M(+70.5%) | $614.10 M(+21.3%) |
Sept 2020 | - | $506.40 M(+26.6%) |
June 2020 | - | $400.10 M(+16.7%) |
Mar 2020 | - | $342.80 M(-4.8%) |
Dec 2019 | $360.20 M(+62.0%) | $360.20 M(+11.7%) |
Sept 2019 | - | $322.40 M(+11.9%) |
June 2019 | - | $288.20 M(+22.4%) |
Mar 2019 | - | $235.40 M(+5.8%) |
Dec 2018 | $222.40 M(+60.1%) | $222.40 M(+14.7%) |
Sept 2018 | - | $193.90 M(+13.5%) |
June 2018 | - | $170.80 M(+36.5%) |
Mar 2018 | - | $125.10 M(-9.9%) |
Dec 2017 | $138.90 M(+35.6%) | $138.90 M(+17.5%) |
Sept 2017 | - | $118.20 M(+12.5%) |
June 2017 | - | $105.10 M(-38.8%) |
Mar 2017 | - | $171.70 M(+67.7%) |
Dec 2016 | $102.40 M(+53.1%) | $102.40 M(+18.9%) |
Sept 2016 | - | $86.10 M(+16.5%) |
June 2016 | - | $73.90 M(+15.3%) |
Mar 2016 | - | $64.10 M(-4.2%) |
Dec 2015 | $66.90 M(+64.8%) | $66.90 M(+13.8%) |
Sept 2015 | - | $58.80 M(+33.0%) |
June 2015 | - | $44.20 M(+19.5%) |
Mar 2015 | - | $37.00 M(-8.9%) |
Dec 2014 | $40.60 M | $40.60 M(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2014 | - | $40.60 M(+14.0%) |
June 2014 | - | $35.60 M(+19.9%) |
Mar 2014 | - | $29.70 M(-7.5%) |
Dec 2013 | $32.10 M(+64.6%) | $32.10 M(+17.2%) |
Sept 2013 | - | $27.40 M(+29.9%) |
June 2013 | - | $21.10 M(+30.2%) |
Mar 2013 | - | $16.20 M(-16.9%) |
Dec 2012 | $19.50 M(+32.7%) | $19.50 M(-4.4%) |
Sept 2012 | - | $20.40 M(+20.3%) |
June 2012 | - | $16.96 M(+5.5%) |
Mar 2012 | - | $16.08 M(+9.4%) |
Dec 2011 | $14.70 M(-2.8%) | $14.70 M(-0.3%) |
Sept 2011 | - | $14.74 M(+7.0%) |
June 2011 | - | $13.78 M(+18.8%) |
Mar 2011 | - | $11.60 M(-23.4%) |
Dec 2010 | $15.13 M(-19.5%) | $15.13 M(-11.0%) |
Sept 2010 | - | $17.01 M(+9.6%) |
June 2010 | - | $15.51 M(-2.0%) |
Mar 2010 | - | $15.83 M(-15.8%) |
Dec 2009 | $18.80 M(+25.3%) | $18.80 M(+7.2%) |
Sept 2009 | - | $17.54 M(+5.5%) |
June 2009 | - | $16.62 M(+10.8%) |
Mar 2009 | - | $15.00 M(+0.0%) |
Dec 2008 | $15.00 M(+77.5%) | $15.00 M(+91.6%) |
Sept 2008 | - | $7.83 M(-9.1%) |
June 2008 | - | $8.61 M(+6.3%) |
Mar 2008 | - | $8.10 M(-4.1%) |
Dec 2007 | $8.45 M(+61.5%) | $8.45 M(+38.3%) |
Sept 2007 | - | $6.11 M(-18.0%) |
June 2007 | - | $7.45 M(+14.6%) |
Mar 2007 | - | $6.50 M(+24.2%) |
Dec 2006 | $5.23 M(-26.1%) | $5.23 M(-20.4%) |
Sept 2006 | - | $6.57 M(+33.4%) |
June 2006 | - | $4.92 M(-29.3%) |
Mar 2006 | - | $6.97 M(-1.5%) |
Dec 2005 | $7.07 M(+351.1%) | $7.07 M(+142.4%) |
Sept 2005 | - | $2.92 M(+1.7%) |
June 2005 | - | $2.87 M(+2.5%) |
Mar 2005 | - | $2.80 M |
Dec 2004 | $1.57 M(+59.4%) | - |
Dec 2003 | $983.90 K | - |
FAQ
- What is DexCom annual total current liabilities?
- What is the all time high annual current liabilities for DexCom?
- What is DexCom annual current liabilities year-on-year change?
- What is DexCom quarterly total current liabilities?
- What is the all time high quarterly current liabilities for DexCom?
- What is DexCom quarterly current liabilities year-on-year change?
What is DexCom annual total current liabilities?
The current annual current liabilities of DXCM is $1.56 B
What is the all time high annual current liabilities for DexCom?
DexCom all-time high annual total current liabilities is $1.84 B
What is DexCom annual current liabilities year-on-year change?
Over the past year, DXCM annual total current liabilities has changed by -$283.30 M (-15.40%)
What is DexCom quarterly total current liabilities?
The current quarterly current liabilities of DXCM is $1.73 B
What is the all time high quarterly current liabilities for DexCom?
DexCom all-time high quarterly total current liabilities is $2.07 B
What is DexCom quarterly current liabilities year-on-year change?
Over the past year, DXCM quarterly total current liabilities has changed by +$12.30 M (+0.71%)